Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 525 of 672 entries
View as:

Efficacy And Safety Of Sofosbuvir/Velpatasvir Fixed Dose Combination With Ribavirin in Chronic HCV Infected Adults Who Participated in a Prior Gilead Sponsored HCV Treatment Study

Phase: N/A Priority: Normal
NCT ID: NCT02300103 Org: User:
Start: 12/01/14 End: 09/15/16 Due: 09/15/17

Study to Compare Tenofovir Alafenamide (TAF) Versus Tenofovir Disoproxil Fumarate (TDF) in Participants With Chronic Hepatitis B Infection Who Are Negative for Hepatitis B e Antigen

Phase: N/A Priority: Normal
NCT ID: NCT01940341 Org: User:
Start: 09/12/13 End: 08/31/22 Due: 08/31/23

Idelalisib With Rituximab, Ifosfamide, Carboplatin, Etoposide (RICE) in Children and Adolescents

Phase: N/A Priority: Normal
NCT ID: NCT03349346 Org: User:
Start: 06/30/19 End: 02/28/26 Due: 02/28/27

Study to Assess Efficacy and Safety of Bulevirtide in Participants With Chronic Hepatitis Delta (CHD)

Phase: N/A Priority: Normal
NCT ID: NCT03852719 Org: User:
Start: 04/17/19 End: 08/08/24 Due: 08/08/25

Study to Evaluate the Safety and Efficacy of Teropavimab and Zinlirvimab in Combination With Lenacapavir in Virologically Suppressed Adults With HIV-1 Infection

Phase: N/A Priority: Normal
NCT ID: NCT04811040 Org: User:
Start: 04/08/21 End: 10/26/23 Due: 10/26/24

Study to Evaluate Safety, Tolerability, and Efficacy of GS-0976 in Adults With Nonalcoholic Steatohepatitis

Phase: N/A Priority: Normal
NCT ID: NCT02856555 Org: User:
Start: 08/08/16 End: 07/18/17 Due: 07/18/18

Phase 1 Trial of Hu5F9-G4, a CD47-targeting Antibody

Phase: N/A Priority: Normal
NCT ID: NCT02216409 Org: User:
Start: 08/31/14 End: 12/31/18 Due: 12/31/19

Registry Study for Patients With Chronic HBV Receiving Nucleotide Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01590615 Org: User:
Start: 04/26/12 End: 04/04/17 Due: 04/04/18

An Extension Study for Subjects Who Are Deriving Benefit With Idelalisib (GS-1101; CAL-101) Following Completion of a Prior Idelalisib Study

Phase: N/A Priority: Normal
NCT ID: NCT01090414 Org: User:
Start: 03/22/10 End: 06/18/18 Due: 06/18/19

Study to Evaluate the Pharmacokinetics of Filgotinib in Participants With Impaired Hepatic Function

Phase: N/A Priority: Normal
NCT ID: NCT03417778 Org: User:
Start: 04/03/18 End: 08/09/18 Due: 08/09/19

Safety, Tolerability, Pharmacokinetics and Antiviral Activity of GS-9669 in Subjects With Chronic Hepatitis C Virus Infection

Phase: N/A Priority: Normal
NCT ID: NCT01431898 Org: User:
Start: 09/30/11 End: 05/31/12 Due: 05/31/13

Simtuzumab (SIM, GS-6624) in the Treatment of Cirrhosis Due to NASH

Phase: N/A Priority: Normal
NCT ID: NCT01672879 Org: User:
Start: 10/29/12 End: 01/03/17 Due: 01/03/18

Study to Compare Tenofovir Alafenamide (TAF) Versus Tenofovir Disoproxil Fumarate (TDF) in Participants With Chronic Hepatitis B Infection Who Are Positive for Hepatitis B e Antigen

Phase: N/A Priority: Normal
NCT ID: NCT01940471 Org: User:
Start: 09/11/13 End: 10/13/22 Due: 10/13/23

A Study of Sacituzumab Govitecan Given at an Alternative Dose and Schedule in Participants With Advanced Triple-Negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06926920 Org: User:
Start: 04/30/25 End: 06/30/28 Due: 06/30/29

Safety and Efficacy of Sofosbuvir Plus Ribavirin in Treatment-Naive Adults With Chronic Genotype 1 or 3 HCV Infection

Phase: N/A Priority: Normal
NCT ID: NCT02074514 Org: User:
Start: 03/31/14 End: 11/30/15 Due: 11/30/16

Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread

Phase: N/A Priority: Normal
NCT ID: NCT03547973 Org: User:
Start: 08/13/18 End: 06/30/30 Due: 06/30/31

Study to Evaluate the Pharmacokinetics of Tenofovir Alafenamide (TAF) in Adults With Normal Hepatic Function and Adults With Severe Hepatic Impairment

Phase: N/A Priority: Normal
NCT ID: NCT02296853 Org: User:
Start: 12/22/14 End: 04/17/15 Due: 04/17/16

Evaluation of Chronic HBV Patients w/Evidence of HBV Replication and Normal or Minimally Elevated Liver Transaminases.

Phase: N/A Priority: Normal
NCT ID: NCT00263614 Org: User:
Start: 12/31/05 End: 06/30/07 Due: 06/30/08

Study With Various Immunotherapy Treatments in Participants With Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05676931 Org: User:
Start: 02/21/23 End: 12/31/27 Due: 12/31/28

Safety and Effectiveness of Giving Adefovir (Preveon) Plus Other Anti-HIV Drugs to HIV-Infected Patients Who Have Not Responded to Other Anti-HIV Drug Combinations

Phase: N/A Priority: Normal
NCT ID: NCT00002398 Org: User:
Start: - End: - Due: -

Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination in Participants With Chronic Genotype 1 HCV Infection

Phase: N/A Priority: Normal
NCT ID: NCT02021656 Org: User:
Start: 12/10/13 End: 09/29/17 Due: 09/29/18

Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Ankylosing Spondylitis Who Have an Inadequate Response to Biologic Disease-Modifying Antirheumatic Drug Therapy

Phase: N/A Priority: Normal
NCT ID: NCT04483687 Org: User:
Start: 12/31/20 End: 09/30/24 Due: 09/30/25

Safety and Efficacy of Voxilaprevir Plus Sofosbuvir/Velpatasvir Fixed Dose Combination in Adults With Chronic Genotype 1 HCV Infection

Phase: N/A Priority: Normal
NCT ID: NCT02378935 Org: User:
Start: 02/17/15 End: 04/12/16 Due: 04/12/17

Evaluation of the Safety, Tolerability, Pharmacokinetics, and Activity of GS-9450 in Subjects With Chronic HCV

Phase: N/A Priority: Normal
NCT ID: NCT00725803 Org: User:
Start: 04/30/08 End: 03/31/09 Due: 03/31/10

Study of the Effect of GS-6615 in Subjects With LQT-3

Phase: N/A Priority: Normal
NCT ID: NCT01849003 Org: User:
Start: 05/31/13 End: 11/30/14 Due: 11/30/15